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Global burden due to diabetes rising steeply affecting 
>422 million individuals worldwide.
[1]
 Its alarming 
prevalence has dreaded impact on health sector due 
to poor quality of life caused by long term 
complications and associated medical cost. The most 
disgusting fact related to diabetes is that despite of 
tremendous effort made by researchers there is still 
no ray of relief is evident in the near future. More 
than 90% of all cases accounts for type 2 diabetes  
and is characterized by insulin resistance as well as 
pancreatic B cell dysfunction (to what extent B cell are 
involved in the pathogenesis is disputable).
[2]
 
Alteration in pancreatic B cell function causes 
impaired  insulin  secretory  response  to   the  glucose 
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and this characterized transition from the pre-diabetic 
to the diabetic state.
[3]
 Recent researches have shown 
that hyperlipidemia plays decisive role in the 
pathogenesis of B cell dysfunction.
[4]
 Association of 
dyslipidemia with diabetes is already well established 
and role of elevated free fatty acids (FFAs) is well 
defined and studied extensively
[5]
 but now one more 
link is added in this pathogenesis. This new linkage is 
hunting the role of cholesterol in glucose- stimulated 
insulin secretion from pancreatic B cell. Cholesterol 
has assigned many important functions in cellular 
domain. One of its major functions is regulation of 
signal transduction through membrane microdomain 
and gene expression through cholesterol- activated 
transcription factors.
[6]
 Intracellular cholesterol 
regulates glucose metabolism and gene expression in 
adipocytes.
[7]
 Disturb metabolism of cholesterol 
(involving synthesis, storage or excretion) could result 
in disruption of any one pathway of  glucose 
stimulated insulin secretion to partial or complete loss 
of secretory functions of pancreatic B cell. Cholesterol 
is a very important bimolecule with diverse functions 
ranging from membrane trafficking and signal 
transduction to its role in embryogenesis.
[8]
 With the 
advancement in science our insight for this miraculous 
biomolecule also enhances lifting the veil from its 
physiological and pathological functions. Cholesterol 
A B S T R A C T  
Role of cholesterol in the pathogenesis of diabetes is the emergent area of research with full of 
potential; it not only open a vast area of therapeutic interventions but also can change the prevailing 
treatment modality. Ayurveda, the Indian system of medicine materialize the concept of lipocenteric 
approach for the management of diabetes even thousands of years back. According to Ayurveda, the 
natural properties of lipid are deranged that causes diabetes. It may prove beneficial to quest the 
search of herbal remedies that can harmonize the lipid balance and uproot the pathogenesis. In the 
presenting review article, role of cholesterol in the pathogenesis of diabetes is discussed along with 
detailed description of Ayurvedic concepts regarding pathogenesis and a brief description of herbal 
management. 
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is present in tissues and in plasma either as free 
cholesterol or as a storage form, combined with a 
long chain fatty acid as cholesteryl ester. Cholesterol 
is required to build as well as to maintain cell 
membrane; it imparts membrane fluidity and 
mobility.
[9]
  Within the cell membrane it also helps in 
intracellular transport, cell signaling and nerve 
conduction.
[10]
 It form lipid rafts along with 
sphingolipids for cellular signaling.
[11]
 Its de novo 
synthesis is a complex process and tightly regulated 
by hormones, HMG Co-A reductase and gene 
transcription.
[12]
 Uptake of cholesterol is measured by 
sterol - sensing protein. Binding of cholesterol to 
sterol sensing protein initiates degradation of HMG-
Co A reductase.
[13]
 The most important step in its 
metabolism is its transport in plasma. In plasma, both 
forms are transported in lipoproteins. Plasma low-
density lipoprotein (LDL) is the vehicle for uptake of 
cholesterol and cholesteryl ester into many tissues. 
Free cholesterol is removed from tissues by plasma 
high - density lipoprotein (HDL) and transported to 
the liver, where it is eliminated from the body either 
unchanged or after conversion to bile acids in the 
process known as reverse cholesterol transport. 
Membrane fluidity as well as curvature is strongly 
modulated by the amount of cholesterol present in 
the membrane and therefore membrane 
microdomains of B cell can enhance cell signaling by 
depleting or overloading cholesterol and modulate 
glucose stimulated insulin secretion (GSIS).
[14]
 
Cholesterol alteration also affects glucose metabolism 
involving glucokinase.
[15]
 Research studies have shown 
that excess cellular cholesterol is directly linked to 
reduced glucose sensitive insulin secretion and also 
that normal secretion can be restored by cholesterol 
depletion.
[16]
 Elevated serum cholesterol causes 
increased cholesterol in pancreatic B cells that directly 
and significantly modulate the insulin secretion 
independent of FFA levels. Thus, it is now postulated 
that cellular cholesterol will be a potential target for 
therapeutic intervention aimed to preserve or 
improve pancreatic B cell functioning through 
modulating GSIS.  Fryris et.al. postulated that 
cholesterol is a key determinant of beta cell 
membrane organization and cell survival.
[17]
 They 
suggest that different lipoprotein classes have varying 
effect on beta cell function and survival. Further they 
concluded that cholersterol can cause B cell loss if 
allowed to accumulate in cell in an unregulated 
manner and therefore it is utmost important to 
maintain beta cell cholesterol homeostasis.  C. Langhi 
and B. Carjou in their article also stated that 
dysregulation of plasma lipoproteins with increased 
TG content in pancreatic B cell leads to lipotoxicity 
and subsequently cell death.
[18]
 They also emphasize 
the role of cholesterol modulators like ATP binding 
cassette transporter A1 and LDL receptor.  
Complement of Cholesterol in Ayurveda 
Kapha is known by a number of synonyms. Of these, 
Shleshma, Bala, Ojas, Mala and Papma are important. 
The former three refer to its normal states of 
functioning, while latter two to abnormal states. 
Kapha is the product of water. The synonym, 
Shelshma, which is used as frequently as the term 
Kapha is derived from the root ‘Shlish Alingane’ 
meaning Shlish is to embrace, to cohere or to keep 
together. Charaka considers that Kapha, in its normal 
states of functioning represent a potential source of 
strength and resistance to disease and decay i.e. Bala 
and Ojas. These terms refer to that power or force 
which resists the factors of decay and disease. Bala 
may be Sahaja (innate, natural or inherited), Kalaja 
(seasonal) and Yuktikrita (acquired). Sushruta has 
used the term Bala to signify Ojas and stated that 
“Bala is the power (of the body) sufficient to resist 
disease”.  
Relation between Kapha (cholesterol) and Meda 
(adipose tissues) 
It has been stated that , among seven Dhatus (the 
seven kinds of primary tissue - elements), Rasa 
(lymphoid plasma), Mamsa (muscle tissues), Medas 
(adipose tissues), Majja (marrow tissues) and Sukra 
(the male reproductive element) are seats of Kapha. It 
has also been stated that the Ojas, a synonym of 
Kapha, is an essential factor of all Dhatus (tissues) of 
the body. 
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Table 1: Showing correlation between Lipids and 




























































































































































Table 2:  Relation between types of Kapha, Lipids 
and related diseases 
Types of 
Kapha 
Lipids Disease due to 
vitiation of Kapha/ 
lipids 
Kledaka Cholesterol present 
in bile acids 
Grahani  
(Steatorrhea), 








Avalambaka Neutral lipids 
including cholesterol, 
phospholipids, 






LDL, VLDL  and 








Dyslipidemia,   
Slesmaka Cholesterol and 
phospholipids 











cholesterol present in 
Dhriti – Smriti 
bhransa (memory 
disorder, 
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Fig. 1: Diagrammatic representation showing  Bio
constituents of  Kapha and Meda Dhatu.
Fig. 2: Biological Functions of Lipids. 
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Fig. 3: Role of Kapha in Metabolism of Lipids.
Fig. 4: Biological functions of 
ent of Diabetes.  
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Vitiated Kapha causing  Prameha (Diabetes Mellitus)
Charaka Samhita has firmly established the 
relationship between obesity and Prameha
of Meda (fat/ adipose tissue) is of great importance in 
the pathogenesis of Prameha. Its role is not only as 
Dushya (disturbed functioning of the 
something more than that. According to Charaka 
Samhita, Bahudrava Shlema (Kapha that c
much liquid) joins and affects Meda, causing it to 
become Abadha (unobstructed or fluid) in nature.
This form of Meda has been described as acting on 
Mamsa (muscle tissue), thereby increasing the 
volume of body fluid. This has been describe
Sharira- Kleda (body fluid) in Ayurveda. Thus, excess 
water in the blood causes increased diuresis. This 
route of pathogenesis for Prameha is closely related 
to obesity. 
The role of Meda  (fat/adipose tissues) is of great 
importance in the pathogenesis of Prameha
not as Dushya (disturbed functioning of the 
but something more than that. According to Charaka 
Samhita, Bahudrava Shleshma (Kapha 
too much liquid) joins and affects Meda
become Abaddha (unobstructed or fluid) in Ayurveda. 
This has been described as Sharira- Kleda
fluid) in Ayurveda. Thus, excess water in the blood 
causes increased diuresis. It is very important to 
elaborate the term Bahudrava Slesma
– Depicting its role in Managem
                  REVIEW ARTICLE
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. Its role is 
Dhatus), 
that contains 
, causing it to 
 (body of 
. Sleshma/ 
Kapha is one among the thr
all physiological and psychological process in the living 
organism. At its normal state it cause binding of body 
tissues i.e. maintain the tissues integrity, represent 
the normal cell mediated immunity etc. 
means that Kapha loses its natural properties and get 
vitiated, it is worthful to mention here that this 
derangement may be acquired or congenital, 
Whatever may be the cause this vitiated 
unable to perform its normal functions. Describing the 
physical properties of Kapha
unctuous in touch and look like 
can be said that Kapha
components of the body and vitiated 
correlated with dyslipidemia. Role of dyslipidemia and 
metabolic abnormalities in the pathogenesis of 
diabetes is very obvious and well elaborated in 
modern medicine. Among the metabolic 
abnormalities that commonly accompany diabetes are 
disturbances in the production and clearance of 
plasma lipoproteins. Moreover, devel
dyslipidemia may be a harbinger of future diabetes. A 
characteristic pattern, termed diabetic dyslipidemia, 
consists of low high density lipoprotein (HDL), 
increased triglycerides, and postprandial lipemia. This 
pattern is most frequently seen in
may be a treatable risk factor for subsequent 
cardiovascular disease.  
Management of Kaphaja 
Use of Herbs 
Acharya Charaka  mentioned a group of ten drugs that 
should be used for scraping the excessive fat known 
as Lekhaniya drugs. All these ten drugs are found to 
have hypolipidemic effects   
Linn.), Kustha (Saussurea lappa
(Curcuma longa Linn.), Daruharidra
D.C.), Vaca (Acorus calamus
heterophyllum Wall.), Katurohani
Royle ex Benth.), Citraka
Cirabilva (Pongamia pinnata
versicolor) are ten drugs given by Acharya Caraka to 
reduce body fats. Charaka Samhita has been cl
to be effective in Medoroga
ent of Diabetes.  
 May-June 2017 
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1. Musta (Cyperus rotandus Linn.): Nagarmotha or 
Musta is reported to have significant 
hypolipidaemic activity.
[20]
 Administration of C. 
rotundus extract at 250 mg/kg and 500 mg/kg as 
well as the hypolipidemic drug, simvastatin at 5 
mg/kg found to caused a significant (p = 0.05) 
decrease in serum total cholesterol and LDL 
cholesterol. Triglyceride was also significantly 
reduced at 500mg/kg extract and simvastatin at 
5mg/kg but the decrease at 250 mg/kg extract 
was not significant. In this study the level of HDL 
cholesterol was significantly (p = .05) increased in 
the treatment groups.
[21]
 Nagarmotha is found to 
increase reabsorption of bile salt and thereby 
regularize the hepatic liposynthesis it reverse 
cholesterol transport pathway, in which HDL 
cholesterol induces an efflux of excess 
accumulated cellular cholesterol and prevents the 
generation of an oxidatively modified LDL. C. 
rotundus is found to reverted the age associated 
increased level of total cholesterol and LDL 
cholesterol to the level of young control rats.
[22]
 
The beneficial effect of cholesterol lowering 
activity of C. rotundus could be attributed to β-
sitosterol and saponin that are well known for 




2. Kustha (Saussurea lappa C.B.Clarke): S. lappa 
Clarke of Compositae is known as Kushta in 
Sanskrit. It is a tall, robust, perennial herb 
distributed in Kashmir. The roots are hot, bitter, 
sweetish, pungent, and flattering. It is used as an 
analgesic, digestive, aphrodisiac and diuretic. 
Some authors have reported that the roots of this 
plant possess cortisol-lowering effect.
[25],[26]
 
Traditionally, aqueous extract of the root of S. 
lappa was used for its anti-anginal effect.
[27]
 The 
hot water extract of the roots has been 
traditionally used for the treatment of 
asthma,
[27],[28]
 inflammations and 
rheumatism.
[29],[30]
 Ethanolic extract of S. Lappa 
showed significant hypolipidemic activity which 
may be due to presence of tannins, triterpenes, 
alkaloids, inulin, essential oil in its root. Treatment 
with ethanolic extract of S. Lappa significantly 
reduced serum and tissue cholesterol, LDL-C. HDL-
C level in both serum and tissue are significantly 
increased by ethanolic extract of S. Lappa.
[31]
 
Saussurea lappa is one of the antioxidant - rich 
medicinal plants.  
3. Haridra (Curcuma longa Linn.): The metabolite of 
C. longa – curcumin (0.5%) is found to significantly 
decrease the cholesterol, LDL, VLDL, triglycerides 
and phospholipids in Streptozotocin-induced 
diabetic rats. In a parallel study, wherein diabetic 
animals were maintained on a high cholesterol 
diet, the extents of hypercholesterolemia and 
phospholipidemia were still higher compared to 
those maintained on control diet. Curcumin 
exhibited lowering of cholesterol and 
phospholipid in these animals also. Liver 
cholesterol, triglyceride and phospholipid 
contents were elevated under diabetic conditions. 
Dietary curcumin showed a distinct tendency to 
counter these changes in lipid fractions of liver. 
This effect of curcumin was also seen in diabetic 
animals maintained on high cholesterol diet. 
Dietary curcumin also showed significant 
countering of renal cholesterol and triglycerides 
elevated in diabetic rats. Curcumin enhances liver 




4. Daruharidra (Berberis aristata D.C.): According  
to Ayurvedic pharmacopeia  of  India, B. 
aristata DC  is  used  in  diabetes.   Diabetes  
mellitus  is  one  of  the  most  common  chronic  
diseases  and  is  associated  with  hyperlipidemia  
and  co-morbidities such as obesity and 
hypertension. B. aristata at the dose of 25 mg/kg 
revealed a significant reduction in serum 
cholesterol, triglycerides and LDL-C.
[38]
 The 
hypolipidemic effects of B. aristata may be due to 
the presence of berberine alkaloid, since 
berberine act at both endothelium and the 
underlying vascular smooth muscle to induce 
relaxation.
[39]
 The  strong  antihyperglycemic  
effect  of  methanolic  extract  of  B. aristata DC  
stem  could  indirectly  be  related  to  beneficial  
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action  against  the  abnormal  high  
concentration  of  serum  lipids  
observed in diabetes rats.
[40]
  
5. Vaca  (Acorus calamus Linn.): A.calamus. Linn. 
(Araceae), commonly known as “sweet flag” or 
“calamus”, is a semiaquatic, perennial, aromatic 
herb with creeping rhizomes. A. calamus. Linn. 
has been used as traditional Indian and Chinese 
prescriptions for its beneficial effects on memory 
disorder, learning performance, lipid peroxide 
content, and anti-aging and anticholinergic 
activity. Moreover, pharmacological studies have 
revealed that Acorus. rhizome and its 
constituents, particularly α.- and β.-asarone, 
possess a wide range of pharmacological activities 
such as sedative, CNS depressant, behavior 
modifying, anticonvulsant, acetylcholinesterase 
inhibitory, memory enhancing, anti-inflammatory, 
antioxidant, antispasmodic, cardiovascular, 
hypolipidemic, immuno suppressive, 
cytoprotective, antidiarrheal, antimicrobial, 
anthelmintic, insecticidal, adulticidal, diuretic, 
antioxidant, genotoxic, and mutagenic 
activities.
[41]
  Administration of the 50% ethanolic 
extract (100 and 200 mg/kg) as well as saponins 
(10 mg/kg) isolated from the extract 
demonstrated significant hypolipidemic 
activity.
[42]
 Apart from its insulin sensitizing effect, 
A. calamus extract  may have hypoglycemic 
effects via mechanisms of insulin releasing and 
alpha-glucosidase inhibition, and thus improves 




6. Ativisa (Aconitum heterophyllum Wall.): Ativisha 
(Aconitum heterophyllum wall) of family 
Ranunculaceae is an Ayurvedic herb which is 
known for its important medical properties. It is a 
tall herb and its roots are tuberous and paried. 
Based on morphology and anatomy, several forms 
of A. heterophyllum are recognized (white, 
Yellow, Black and Red) amongst which the white 
variety is the best.
[44]
  Aconitum heterophyllum is 
an endangered Himalayan plant. The 
subterranean part of the plant is used for the 
treatment of diseases like nervous system 
disorders, fever, diarrhea, obesity, etc. The A. 
heterophyllum treatment markedly lowered total 
cholesterol, triglycerides and apolipoprotein B 
concentrations in blood serum. It also showed 
positive effects (increase) on serum high-density 
lipoprotein cholesterol (HDL-c) and apolipoprotein 
A1 concentrations. On the other hand, A. 
heterophyllum treatment lowered HMG- Co A 
activity, which helps to reduce endogenous 
cholesterol synthesis and also activated lecithin-




7. Katurohani (Picrorhiza kurroa Royle ex Benth.): 
Due to high Glycoside content it has potent anti-
hyperlipidemic activity. The alcoholic, chloroform 
and aqueous root extracts of  P. kurroa Royle ex 
Benth showed significant antihyperlipidemic 
activity in Triton wr- 1339 induced albino rats with 
Atorlip-20 as reference standard.
[46]
 It enhances 
the bile secretion through liver, improve the 
reestrification of  long chain fatty acids and 
increase the production of HDL.  
8. Cirabilva (Pongamia pinnata Merr.): Cirabiva is 
one among four varieties of Karanja - an ancient 
Ayurvedic herb described in Rigveda and 
Atharvaveda. It is mainly use to pacify Kapha-Vata 
Dosha. Methanolic extract of flower and pod of P. 
pinnata showed significant hypoglycemic activity 
in the Streptozotocin induced diabetic rats.
[47]
 
Insulin deficiency or insulin resistance is 
associated with hypercholesterolemia and 
hypertriglyceridimia.
[48]
 P. pinnata pod and flower 
extract are found to significantly decrease the 
level of cholesterol, LDL, VLDL, triglycerides and 
increase the level of HDL. HDL improves the 
reverse cholesterol transport that further 
improves the removal of excessive cholesterol 
from non-hepatic tissues to liver thereby 
enhancing its excretion in the form of VLDL. 
9. Citraka (Plumbago zeylanica Linn.): P. zeylanica 
Linn. extract is found to decrease intestinal 
cholesterol absorption and lower the activity of 
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lipogenic enzymes like HMG CoA reductase in the 
liver thus also helps in decreasing the 
cholesterogenesis. Additionally it also reduced the 
total lipid content in the liver. Moreover, the 
aqueous extract demonstrated a potential 




10. Hemavati (Iris versicolor): It is a controversial 
drug because in Samhita the term Hemavati is 
also used for Vaca ( Acorus calamus),  but in this 
context Vaca is already described therefore Iris 
versicolor is taken for Hemavati. Very few 
scientific research studies are available for 
evaluating hypolipidemic effect of Iris versicolor. 
One such study showed  its effect on 
norepinephrine stimulated fat cells where it 
increases the concentrations of glycerol and FFA 
further and increase in FFA can be accounted for 
the reduction in the process of reesterification. It 
is known that reesterification occurs concurrently 
with liberation of FFA during the process of 
lipolysis, and L. glycerophosphate is required. This 
result indicates that this has independent lipolytic 
effect on adipose tissue to mobilize fat. The 
lipolytic effect on adipose tissue may be directly 
and/or through catacholamines. There are 
evidences that central neuron system had ability 
to specifically control lipid mobilization without 
affecting glucose homeostasis. As for the 
neurochemistry is concerned, norepinephrine, 
released from brain neurons (by the action of 
drugs) mobilizes FFA in rats by activation of B 
receptors in the adipocyte plasma membrance.
[50]
 
11. Guggulu (Commiphora mukul): The gum resin of 
the Commiphora mukul is found to possess 
hypolipidemic activity. In an experiment, in-vitro 
administration of  Commiphora mukul gum resin 
extract and medium-chain triglyceride found to 
significantly reduced low-density lipoprotein 
cholesterol and increased the high-density 
lipoprotein/low-density lipoprotein ratio. The 
combination showed direct inhibition of HMG-
CoA  reductase activity in a dose-dependent 
manner and compared very well with the 
inhibitory effect of statins like Pravastatin and 
Mevastatin. The adipocyte differentiation was 
also inhibited. It is found to increased the AMPKα  
phosphorylation and AMPK kinase activity and 
inhibited the phosphorylated form of mTOR 
expression. It also highly upregulated the 
expression of LXR and PPARα genes and 
moderately upregulated BABP and SHP genes.
[51]
 
12. Sunthi (Zinziber officinalis): It has been found that 
oral administration of ginger extract showed 
hypolipidemic effect in Vanaspati supplemented 
rats.
[52]
  Zinziber extract lowers the lipid level by 
disrupting the cholesterol absorption and also by 
inhibiting liver lipogenesis.
[53],[54]
 Evidence suggest 
that ginger contains antioxidant properties which 
have a hypocholesterolemic effect and anti-
atherogenic and these activities might be 
attributed to the inhibition of LDL oxidation and 
the suppression on the activity of HMG-CoA (3-
hydroxy- 3methyglutaryl co-enzyme A) 
reductase.
[55]
 This also might occur due to the 
elevation of hepatic cholesterol 7-alpha-
hydroxylase activity, which is a rate-limiting 
enzyme in the biosynthesis of the bile acids and 
stimulates the conversion of cholesterol to bile 




Use of  Herbo- Mineral Preparation - Arogyavardhini 
Vati, a traditionally used Ayurvedic medicine may be a 
useful therapy for hypercholesterolemia through 
reducing oxidative stress (decreasing MDA and 
increasing GSH) and lipid levels. Arogyavardhini 
Vati significantly decreased serum cholesterol, 
triglyceride, LDL, and C-reactive protein (CRP) and 
significantly increased serum HDL in a dose-
dependent manner. Decreased MDA and increased 
GSH levels in liver were observed at all doses 
of Arogyavardhini Vati (50, 100, 200 mg/kg) and 
fenofibrate - treated groups when compared with 
Triton-treated group. Atherogenic Index (AI) level was 
significantly decreased in fenofibrate and 
Arogyavardhini Vati (200 mg/kg) treated rats when 
compared with normal control.
[57]
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Pancakarma Procedures: Purificatory procedures of 
Panchakarma are extremely helpful in maintaining 
the homeostasis of lipids in blood.   
Role of Vamana:  Expulsion of vitiated Doshas 
through oral route is known as Vamana. Procedure of 
Vamana consist of following steps: 
 Step I - Deepan - Pachan (use of carminative and 
digestive drugs) with Panchakola Churna (mixture 
of Piper longum, Plumbago zeylanica, Zingiber 
officinale, Piper chaba Hunter powder in equal 
amount) powder  in the dose of 3gm given twice 
in day with lukewarm water-orally for 3 days. 
 Step II - Snehapan (oleation therapy) with 
Triphala Ghrita - orally 3-7 days in the increasing 
order dose to be decided according to the 
Koshtha, Prikriti, Satva and Agni of the patients. 
 Step III - Vamana Karma - Paste of  Madanphala 
Churna - 5gm, Vacha Churna - 3gm, Saindhav 
Lavana - 2gm, Madhu - 5gm, Milk - 4 liter- orally - 
O.D /Madhuyasti Phanta/ nimbadi kwath - 3 liter-
orally - O.D 
Role of Lekhaniya Basti: Lekhan basti is mentioned by 
different Acharyas for Kaphaja Roga (diseases due to 
dyslipidemia, hypercholesterolemia) and Kaphavrita 
Vata. The word Lekhana itself indicates its action 
means - "Lekhanam Karshanam". Thus Lekhan is 
nothing but a process of emaciation while 
Sharangadhara considered Lekhana in a wide sense, 
i.e. Lekhan is a process of drying up or desiccation of 
all excess Dosha, Dhatu and Mala i.e. "Deha 
Vishosanam ". The drugs of Lekhan Basti are 
described as follow, 
1. Kwatha  Dravya (drug used for decoction)-  (a) 
Triphala- 30 gm (b) Nagarmotha-10gm (c) 
Guduchi- 10gm (d) Amalthas- 10 gm (e) 
Madanphala – 10 gm 
2. Kalka Dravya (drug used for making paste): 
Triphla churna – 5gm  Yavakshar churna- 5gm,  
Pippali churna – 5gm, Madhuyasti churna- 5 gm + 
Madhu -25 gm +Sarshap Tail- 50 ml + Gomutra- 
150 ml  
Note: These quantities are required for preparation of 
300 ml of Lekhaniya Basti. 
Rasayana Therapy:  In Charaka Samhita, Acharya 
Charka descried a cluster of symptoms that appears 
due to faulty dietary habits, faulty life style and faulty 
thoughts what we know today as Metabolic 
Syndrome.  Acharya says that excessive use of 
cultivated grains, vegetable, fruits and poultry 
products without appropriate work out (exercise), 
sedentary life style, unstable emotions like excessive 
fear, grief, greed, stress, etc. produces an array of 
syndrome that should be treated with Rasayana only.  
The success of Rasayana therapy lies mainly in its 
multi-pronged approach in controlling health, while 
pacifying the disease. As any other therapy, this also 
has a set of rules to be adapted for its application. The 
outcome of Rasayana therapy depends upon the 
degree of adapting and observing these procedures. 
That includes Purvakarma (before procedures), 
Pradhanakarma (main procedure) and 
Pashcatakarma (after procedures). 
Purva karma includes the Samana and Sodhana 
Cikitsa, to have a purified body (Suddha Sharira), in 
which a suitable Rasayana Aushadha can be 
administered. The administration of a suitable 
Rasayana Aushadha becomes the Pradhana Karma in 
the context of Rasayana therapy. During the 
Rasayana treatment and after the completion of the 
treatment, one has to adhere to the Acara Rasayan 
(moral ethics), which consists of instruction for using 
diet and life style after Rasayana therapy, this is 
known as Pashcat Karma. Pashcat Karma consists of 
Parihara Kala, which is twice the duration of 
Pradhana Karma. After the Parihara Kala, the 
individual is allowed to use normal diet. 
Rasayana useful for Kaphaja Disorders 
1. Bhallataka (Semecarpus anacardium Linn): 
Acharya Charaka says that there is no Kaphaja 
disorder on earth that can’t be cured by 
Bhallatak. Acharya Charak describe Kalpa use of 
Bhallatak starting with 10 Bhallatak fruit, 
increasing one every day reaching upto 30 and 
then decreasing gradually to 10 Bhallatak thus 
total of 1000 Bhallatak can be used but never be 
more than this. The doses described by Acharya in 
Divya Kajaria. Cholesterol & its Ayurvedic Complement – Depicting its role in Management of Diabetes.  
ISSN: 2456-3110                                                      REVIEW ARTICLE May-June 2017 
 
Journal of Ayurveda and Integrated Medical Sciences | May - June 2017 | Vol. 2 | Issue 3 133 
 
Samhitas are much more that can be tolerated by 
human in present time, therefore it is 
recommended that physician should modify the 
doses according to the patient strength. 
Days Doses of Bhallatak 
1
st



























 Day 17 Bhallatak 
49
th
 Day – 54
th









 Day 11 Bhallatak 
 Total 1000 Bhallatak 
Bhallatak should always be taken with milk to avoid 
mouth ulcers, gastritis etc. Acharaya Charak described 
10 different dietary items of Bhallatak for use viz. 
milk, ghrita, honey, jaggery, etc. 
2. Shilajita (Asphaltum): Shilajita Rasayan can be 
used in three ways – Pravara (maximum dose), 
Madhyam (moderate dose) and  Avara (minimum 
dose).  For maximum dose  Shilajita is used in the 
dose of  4 Tola (= 46gm approx) for seven weeks, 
for moderate dose 2 Tola (=23gm approx) is used 
for three weeks and for minimum dose 1 Tola 
(=11.5gm approx). Shilajita is used for one week. 
During Shilajita use patient should be kept on milk 
diet.  
3. Pippali Rasayan (Piper longum): For Rasayan 
purpose Pippali can be use in following methods: 
 Pippali Vardhmana Kalpa - In this method dose of 
Pippali is escalated and then reduced gradually. 
For 10 days dose of Pippali powder is increased as 
10 Pippali powder daily and then for 10 days its 
dose is reduced as 10 Pippali daily, thus total of 
1000 Pippali is used keeping patient only on milk 
diet. 
 Pippali Naimittika Rasayana - In this method, 
powder of 3 Pippali fruits is daily boiled with milk 
and taken empty stomach (method of 
preparation: Pippali powder + 250 ml of milk and 
250ml of water boiled till only milk remains, then 
should be taken once in a day). 
 Powder of 5,7,8 or 10 Piper longum fruit can be 
taken with honey and Ghrita for the purpose of 
Rasayan. Piper longum fruit is firstly soaked in 
Palasha Kshara and then dry to make powder. 
Powder of three Pippali should be taken in 
morning, before meal and after meal thrice time 
in a day for the desired effect of Rasayan.  
Indication for using Pippali Vardhamana Rasayana 
a) Patients without any major complication 
(bleeding diathesis, gastritis, malena etc.) 
b) Patients with strong body built, strength, and 
good mental stamina (Pravara Satva). 
c) Should be used in patients with chronic liver 
diseases, liver cirrhosis, and other autoimmune 
liver disorders. 
Indication for using Pippali Naimittika Rasayana 
a) Patients having complicated Cirrhosis (Cirrhosis 
with PHTN or Oesophageal varices). 
b) Those who cannot tolerate Pippali vardhamana 
kalpa and patients in which  vardhamana kalpa is 
contraindicated. 
4. Triphala: Triphala means powder of three fruits 
namely Haritaki (Terminalia chebula), Amalaki 
(Emblica Officinalis) and Bibhitaki (Terminalia 
Bellerica). For Rasayan purpose powder of one 
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Haritaki fruit should be taken after digestion of 
food (i.e. morning), powder of two 
taken before meal and powder of four 
taken after meal. Triphala paste painted 
an iron utensil for whole night and then taken in 
morning with honey and water also work as 
Rasayan and is very useful in Kaphaja
Equal amount of Triphala powder and 
powder  taken daily can also use for 
purpose. 
Fig. 5: Diagrammatic representation showing role of 
Lekhaniya drugs on Meda 
CONCLUSION 
Thus it is very clear that cholesterol has a definite role 
in insulin secretion through pancreatic B cell and 
hypolipidemic agents may prove beneficial in the 
management of diabetes. Use of herbs is the safest 
and cheapest way for scraping the accumulated 
cholesterol in the most natural manner. Purification 
therapy (Panchakarma therapy) and Rejuvenation 
therapies are very beneficial for disrupting the vicious 
cycle of hyperlipidemia and insulin resistance and 
prevent or minimize the complications.  
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